Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Marc Stuart Zumberg, MD
Healthcare Provider Physician
UF Health Hematology
1549 Gale Lemerand Drive
3rd Floor
Gainesville, Florida, United States
Dr. Zumberg is recognized as an outstanding clinician-educator in the division of haematology/oncology and the department of medicine. He serves as section chief for benign haematology and holds various medical directorships. He is chairman of the Shands Hospital Transfusion Committee. He is noted as a key clinical faculty member in the internal medicine residency training program and the division of haematology/oncology fellowship program. His clinical interest cover various diseases which includes anaemia, sickle cell anaemia, sickle cell anaemia – resources, sickle cell test, deep vein thrombosis, hemochromatosis, idiopathic thrombocytopenic purpura (ITP) and thrombocytopenia.
Dr. Zumberg also provides outpatient, new patient, and follow-up services at the outpatient Davis Cancer Center. He serves as the medical director of Therapeutic Aphaeresis for Lifesouth, the region’s blood provider. He is also the medical director for the Shands-UF Outpatient Anticoagulation Clinic. He serves as chairman for the Transfusion Committee at Shands Hospital. His research interests are in ITP, sickle cell disease, and other areas of benign haematology.
+myBinderRelated Content
-
Russell Ware, MD, PhDRussell Ware, MD, PhD, has been involved...
-
Clayton Andrews, LAPCClayton Andrews is a 35-year-old patient...
-
Nationwide Children’s HospitalThe Comprehensive Sickle Cell and Thalas...
-
Improving Quality of Care for Sickle Cell Patients in the Pediatric Emergency DepartmentOBJECTIVE: The aim of this study was to ...
-
Today’s Faces of Sickle Cell Disease: Wanda Whitten-Shurney, MDWanda Whitten-Shurney is a pediatrician,...
-
Opioid management strategy decreases admissions in high-utilizing adults with sickle cell diseaseBackground: A subset of adults with sic...
-
Gene-Therapy Company Crispr Drops as FDA Puts Trial on HoldCrispr Therapeutics AG plunged after the...
